Atossa Therapeutics, Inc. (ATOS)
| Market Cap | 520.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.92M |
| Shares Out | 92.59M |
| EPS (ttm) | -0.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 11 |
| Last Price | $4.31 |
| Previous Close | $4.07 |
| Change ($) | 0.24 |
| Change (%) | 5.90% |
| Day's Open | 4.46 |
| Day's Range | 4.12 - 4.49 |
| Day's Volume | 13,891,644 |
| 52-Week Range | 0.81 - 6.82 |
The sell-off resulted from the company's announcement of phase 2 data for experimental breast cancer drug endoxifen.
SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
The company might announce some extremely good news later this week.
Today, ATOS stock is taking off on the veiled announcement of the release of some Phase 2 study data for one of the company's leading drugs. The post ATOS Stock: What Is the Big Catalyst for Atossa Ther...
AMC stock ignites momentum in small cap penny stocks this month. The post Hot Penny Stocks To Watch As AMC Stock Ignites Small Caps In June appeared first on Penny Stocks to Buy, Picks, News and Informa...
Atossa Therapeutics Inc. (NASDAQ:ATOS) shares are trading higher Monday after the company announced it will release the final data from its Phase 2 study of endoxifen administered to breast cancer patie...
SEATTLE, June 07, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infec...
Reddit penny stocks are back in focus as AMC stock rises; which 3 are you watching? The post Reddit Penny Stocks to Buy?
An analyst tracking the stock gets even more bullish on its prospects.
SEATTLE, May 27, 2021 /PRNewswire/ -- DRASTIC Investigator Gilles Demaneuf and Physician-Scientist Dr. Steven C. Quay, M.D.
SEATTLE, May 21, 2021 /PRNewswire/ -- Physician-Scientist Dr. Steven C. Quay, M.D.
Looking for 7 penny stocks that could be buy the dip candidates? Check these out The post 7 Penny Stocks to Watch With Crypto News Sparking a Market Dip appeared first on Penny Stocks to Buy, Picks, New...
These penny stocks shot up big today; should they be on your watchlist? The post Are These Penny Stocks on Your May Watchlist?
InvestorPlace is closing out a busy week of trading with a look at the Reddit penny stocks seeing the most chatter on Friday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared first...
These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on I...
SEATTLE, May 14, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infect...
SEATTLE, May 14, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner. The post 7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts appe...
SEATTLE, May 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?
Reddit penny stocks continue to see momentum; here's 4 to watch with higher than average volume The post 4 Hot Reddit Penny Stocks With Higher Than Average Volume appeared first on Penny Stocks to Buy, ...
Reddit penny stocks to watch as May 2021 gets kicked off The post Best Penny Stocks To Buy In May 2021? Take A Look At These Right Now appeared first on Penny Stocks to Buy, Picks, News and Information ...
Biotech penny stocks are back in focus; should these 3 be on your watchlist? The post Top Biotech Penny Stocks on Reddit?
SEATTLE, April 30, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific...
Investors can seem to get enough of Reddit penny stocks news and we're looking at the most talked-about ones for Thursday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared first ...
Penny stocks present opportunities to buy the dip often; is that the case with these biotech stocks? The post Hot Penny Stocks to Watch; Is it Time to Buy The Biotech Dip?
SEATTLE, April 08, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific...
SEATTLE, March 31, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infe...
SEATTLE, March 30, 2021 /PRNewswire/ -- An Open Letter concerning the WHO Report was published today by Dr. Steven Quay, M.D., PhD., CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS), entitled, "To Stop t...
Atossa Therapeutics Inc (NASDAQ: ATOS) shares are trading lower after the company announced it priced its $50 million registered direct offering at the market. Atossa is a clinical-stage pharmaceutical ...
SEATTLE, March 22, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (the “Company” or “Atossa”), a clinical-stage biopharmaceutical company seeking to discover and develop innovative me...
SEATTLE, March 11, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signific...
It's fine to own ATOS stock based on the Covid-19 angle, but a broader view of the company reveals a commitment to under-treated conditions. The post Atossa Therapeutics Has a Covid-19 Connection and Mu...
Atossa Therapeutics Inc (NASDAQ: ATOS) announces final results from its Phase 1 study evaluating AT-301 administered by nasal spray. AT-301 is being developed for at-home use for patients recently diagn...
SEATTLE, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significa...
Investors are excited about the potential of the biotech's experimental breast cancer treatment.
Atossa Therapeutics (ATOS) stock is on the rise with heavy trading Thursday after announcing some positive breast cancer news. The post ATOS Stock: 8 Things for Investors to Know About Atossa Therapeuti...
SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
SEATTLE, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
SEATTLE, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
SEATTLE, Jan. 29, 2021 /PRNewswire/ -- A paper was published today by Dr. Steven Quay, M.D., PhD., CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS), entitled, "A Bayesian analysis concludes beyond a reas...
SEATTLE, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significan...
HOUSTON, Jan. 8, 2021 /PRNewswire/ -- Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NASDAQ: ATOS ), recently shared his latest research and finding...
SEATTLE, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (the “Company” or “Atossa”), a clinical-stage biopharmaceutical company seeking to discover and develop innovative med...
SEATTLE, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (the “Company” or “Atossa”), a clinical-stage biopharmaceutical company seeking to discover and develop innovative med...
SEATTLE, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significa...
SEATTLE, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significa...
SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significa...
SEATTLE, Oct. 28, 2020 /PRNewswire/ -- A paper published on Zenodo (DOI 10.5281/zenodo.4119263) by Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NA...
SEATTLE, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significa...
About ATOS
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; AT-H201, a drug candidate to improve lung function in COVID-19 patients; and immunotherapy/chimeric antigen receptor therapy p... [Read more...]
| Industry Biotechnology | IPO Date Nov 8, 2012 |
| CEO Steven Quay | Employees 6 |
| Stock Exchange NASDAQ | Ticker Symbol ATOS |
Analyst Forecasts
According to 2 analysts, the average rating for ATOS stock is "Buy." The 12-month stock price forecast is 7.50, which is an increase of 74.01% from the latest price.